Graceway's Zyclara approved in the US for actinic keratosis
This article was originally published in Scrip
Executive Summary
The US FDA has approved Graceway Pharmaceuticals' Zyclara (imiquimod cream 3.75%) for the treatment of clinically typical, visible or palpable actinic keratoses (AK).